Bartonella bacteria found in hemangiosarcoma tumors from dogs

Credit: CC0 Public Domain

Researchers from North Carolina State University have found a very high prevalence of Bartonella bacteria in tumors and tissues—but not blood samples—taken from dogs with hemangiosarcoma, a cancer of the blood vessels. The work further supports the connection between persistent infection and some types of cancer and adds to the evidence that Bartonella can remain and thrive, undetected, within tissue.

Hemangiosarcoma (HSA) is an aggressive, deadly cancer that arises from cells lining the . It is responsible for two-thirds of all heart or splenic tumors in dogs, and is most common in medium-sized and middle-aged dogs. Since HSA usually cannot be diagnosed without major abdominal surgery, most HSA remains undetected until it has reached an advanced stage, resulting in a one-year survival rate of only 12 to 20%.

"There are clear precedents for the involvement of bacterial infections in tumor development," says Ed Breitschwerdt, Melanie S. Steele Distinguished Professor of Medicine at NC State's College of Veterinary Medicine and corresponding author of a paper describing the work. "Given the established links between and cancer, we wanted to determine whether chronic infection of vessels due to bacteria could be a contributing cause of this cancer."

Breitschwerdt and colleagues from NC State looked at tumor tissue, non-tumor tissue and from 110 dogs with HSA from across the U.S. They screened both the tissues and the blood for Bartonella, Babesia, and Mycoplasma, three bacteria associated specifically with blood infections.

Bartonella DNA was amplified and sequenced from 80 of the dogs with HSA: it was present in 34% of tumor tissue and 63% of non-tumor tissue, but appeared in none of the blood samples. Mycoplasma DNA was only amplified from 5 of the dogs and Babesia wasn't detected in any dog.

"Research in recent years has confirmed that with or inflammation caused by stealth pathogens is a risk factor for developing cancer later in life," Breitschwerdt says. "With the exception of Helicobacter pylori, the emphasis on evaluating the relationship between infection and cancer has focused on viruses. But intracellular bacterial pathogens such as Bartonella may also play an important and previously uninvestigated role.

"Bartonella is a stealth pathogen—it can 'hide' in the cells that line blood vessel walls, which is part of what makes it so difficult to detect," Breitschwerdt says. "This work adds more evidence to the connection between infection and cancer risk, and demonstrates that molecular testing of whole blood samples does not rule out the presence of this pathogen. Future studies are needed to investigate whether Bartonella infection can be a cause of HSA. Our team will be focusing on creating more sensitive diagnostic testing as part of this effort."

More information: Erin Lashnits et al, Molecular prevalence of Bartonella, Babesia, and hemotropic Mycoplasma species in dogs with hemangiosarcoma from across the United States, PLOS ONE (2020). DOI: 10.1371/journal.pone.0227234

Journal information: PLoS ONE

Citation: Bartonella bacteria found in hemangiosarcoma tumors from dogs (2020, January 16) retrieved 24 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Bartonellosis: Diagnosing a stealth pathogen


Feedback to editors